These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 23085247)
1. Epidemiology and prognostic determinants of bacteremic acute pyelonephritis in women. Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Pitart C; Mensa J J Infect; 2013 Feb; 66(2):193-6. PubMed ID: 23085247 [No Abstract] [Full Text] [Related]
2. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. Lee SS; Kim Y; Chung DR J Infect; 2011 Feb; 62(2):159-64. PubMed ID: 21055417 [TBL] [Abstract][Full Text] [Related]
3. A simple intervention to reduce inappropriate ciprofloxacin prescribing in the emergency department. Fagan M; Lindbæk M; Reiso H; Berild D Scand J Infect Dis; 2014 Jul; 46(7):481-5. PubMed ID: 24552583 [TBL] [Abstract][Full Text] [Related]
4. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis. Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876 [TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Sandberg T; Skoog G; Hermansson AB; Kahlmeter G; Kuylenstierna N; Lannergård A; Otto G; Settergren B; Ekman GS Lancet; 2012 Aug; 380(9840):484-90. PubMed ID: 22726802 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis: a prospective multicentre study. Wie SH; Ki M; Kim J; Cho YK; Lim SK; Lee JS; Kwon KT; Lee H; Cheong HJ; Park DW; Ryu SY; Chung MH; Pai H Clin Microbiol Infect; 2014 Oct; 20(10):O721-9. PubMed ID: 24330047 [TBL] [Abstract][Full Text] [Related]
7. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network]. Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis. Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820 [TBL] [Abstract][Full Text] [Related]
9. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. Chang UI; Kim HW; Wie SH Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department. Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271 [TBL] [Abstract][Full Text] [Related]
11. Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women. Wie SH; Kim HW; Chang UI Clin Microbiol Infect; 2014 Nov; 20(11):1211-8. PubMed ID: 24909648 [TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis. Waugh J; Keating GM Drugs Aging; 2004; 21(1):55-64; discussion 65-6. PubMed ID: 14715044 [TBL] [Abstract][Full Text] [Related]
13. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis. Chang UI; Kim HW; Wie SH Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969 [TBL] [Abstract][Full Text] [Related]
15. Study finds surprising amount of bacterial resistance to standard antibiotic treatment of kidney infections. Rep Med Guidel Outcomes Res; 2000 Mar; 11(7):8-10. PubMed ID: 11795320 [No Abstract] [Full Text] [Related]
16. [Ceftriaxone: whether there is future for it?]. Sidorenko SV Antibiot Khimioter; 2006; 51(8):3-9. PubMed ID: 18030778 [No Abstract] [Full Text] [Related]
17. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis. Chang UI; Kim HW; Noh YS; Wie SH Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668 [TBL] [Abstract][Full Text] [Related]
18. Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women. Chang UI; Kim HW; Wie SH Antimicrob Agents Chemother; 2015 May; 59(5):2488-95. PubMed ID: 25645837 [TBL] [Abstract][Full Text] [Related]
19. [Current role of aminoglycosides in the treatment of acute pyelonephritis]. Caron F Prog Urol; 1998 Dec; 8(6):1077-9. PubMed ID: 9894273 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis. Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]